evolution plasmid vivo strain staphylococcus aureus strain staphylococcus aureus far4 isolated patient frequent interval 18 month strain previously shown lose resistance several antibody lacey et al 1973 last 6 month change occurred vivo lincomycin resistance appeared patient treated clindamycin due mutation constitutive resistance lincomycin erythromycin locus adjacent determining inducible resistance erythromycin locus probably carried extrachromosomal element three type variation pf plasmid observed alteration production penicillinase macroconstitutive microconstitutive associated detectable change plasmid size change gave cell advantage vitro associated faster growth rate probably also vivo microconstitutive variant isolated increasing number flucloxacillin therapy ceased complete loss determinant penicillinase production resistance cadmium ion pf plasmid associated decrease plasmid size 4 x 10 6 dalton change also associated increased growth rate vitro loss resistance fusidic acid pf plasmid associated decrease plasmid size 1 x 10 6 dalton